Influence of dietary prebiotics in ulcerative colitis

  • Research type

    Research Study

  • Full title

    A randomised, placebo-controlled, double-blinded crossover trial investigating the effect of a dietary prebiotic on clinical, metabonomic, microbiological, and immunological outcomes in patients with mild to moderate ulcerative colitis

  • IRAS ID

    325815

  • Contact name

    Glenn Gibson

  • Contact email

    g.r.gibson@reading.ac.uk

  • Sponsor organisation

    University of Reading

  • Clinicaltrials.gov Identifier

    NCT06050811

  • Duration of Study in the UK

    2 years, 6 months, 31 days

  • Research summary

    This study will look at whether prebiotics can improve symptoms for people living with Ulcerative Colitis (UC). This project will have two sections: First, a 'batch culture' gut model will be used to study the effect of various prebiotics on the microbes in stool from patients with UC. A prebiotic which works best in a gut model in the lab will then be taken forward to a clinical trial in people with active UC. This trial will look at the effect of the prebiotic compared to a placebo on bowel symptoms and key changes in participants' metabolism and immune system. The cross-over design of the trial means patients are their own control subjects. Patients will take either the prebiotic or a placebo for 28 days, then have a 21 day period with no product, then
    swap to the other treatment for another 28 days. We plan to recruit 40 participants over 12-18 months. During the study they will keep diaries of their symptoms, and provide blood, urine and stool samples at weeks 0, 4, 7, 10 and 14. This project is novel for a few reasons. It will be the first ‘bench-to-bedside’ study into the use of prebiotics in IBD. We will also be carrying out a 'functional assessment' to look at how the microbes interact with the human host and a food based therapy for UC would not suppress the immune system, unlike many drugs we currently use.

  • REC name

    North West - Greater Manchester South Research Ethics Committee

  • REC reference

    23/NW/0080

  • Date of REC Opinion

    23 Mar 2023

  • REC opinion

    Further Information Favourable Opinion